Newsletter

Affiliates of New Mountain Capital Acquire Aegean Corporation

Aegean Corporation (AEGN) announced on February 16 that the company entered into a definitive agreement for an acquisition by affiliates of New Mountain Capital, LLC. Aegean’s stockholders will receive a cash payout of $26 per share, which is a 28% premium over the stock’s 30-day moving average price. The deal values the enterprise at $963 […]

0Comments

Gilat Satellite Networks Awarded Contract for Telecom Systems at Peruvian Airports

Gilat Satellite Networks, Ltd. (GILT) announced on February 4 that the company was awarded a multi-million-dollar contract. Under the terms of the contract, Gilat will provide mission telecom systems for 29 airports in Peru. Gilat, a global leader in satellite-based broadband communications, has successfully completed several other large government projects in Peru.   Jet Equities […]

0Comments

Sorrento Therapeutics Reports Promising Phase 1b Results of COVI-MSC in COVID ICU Patients

On January 26, Sorrento Therapeutics, Inc.  (SRNE) announced preliminary results from a Phase 1b study of COVID-MSC for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS). COVI-MSC is an infusion treatment of human allogeneic adipose-derived mesenchymal stem cells. The three patients in the study experienced no infusion-related adverse effects […]

0Comments

IZEA Lands Seven-Figure Contract Award

On January 12, IZEA Worldwide, Inc. (IZEA) announced that the company received a seven-figure contract award from a Fortune 100 retailer. The retailer is an existing client that expanded its marketing program with IZEA through 2021. Under the terms of the contract, IZEA will provide managed services and licensing of IZEA’s BrandGraph software. IZEA is […]

0Comments

Diana Shipping Announces New Time Charter Contracts

On January 8, Diana Shipping, Inc. (DSX) announced that it has entered into two new time charter contracts with Cargill International. Both the m/v Santa Barbara and m/v Salt Lake City contracts total $11.89 million in revenue over the scheduled time periods. The m/v Santa Barbara contract lasts until at least January 2, 2022. The […]

0Comments

PerkinElmer Will Acquire Oxford Immunotec Global

PerkinElmer, Inc. announced on January 7 that it will acquire lab diagnostics company Oxford Immunotec Global PLC (OXFD). Under the terms of the acquisition, Oxford Immunotec shareholder will receive USD $22 per share in cash for their stake in the company. The agreement values Oxford Immunotec at around $591 million. This is a 28.3% premium […]

0Comments

Curis Updates Phase 1 Clinical Trial Results for Non-Hodgkin’s Lymphoma Treatment

On December 8, Curis, Inc. (CRIS) presented updated data on its Phase 1 clinical trial of CA-4948, an IRAK4 kinase inhibitor to treat patients with relapsed or refractory (R/R) non-Hodgkin’s lymphoma (NHL). The treatments was well tolerated by patients, and 6 out of 7 experienced anti-cancer activity marked by a decrease in tumor burden. As […]

0Comments

FDA Approves ORLADEYO by BioCryst for to Prevent HAE Attacks

On December 3, BioCryst Pharmaceuticals, Inc. (BCRX) announced that the FDA approved oral, once-daily ORLADEYO™ (berotralstat) to prevent hereditary angioedema (HAE) attacks in adults and pediatric patients over the age of 12. This is the first oral non-steroidal treatment option for people with HAE. In the Phase 3 clinical trial, ORLADEYO™ significantly reduced HAE attacks […]

0Comments